We are excited to announce the launch of a monthly tumor board series focusing on the latest precision-medicine based and rare disease treatment protocols. These tumor boards will be led by a Key Opinion Leader and supported by a panel of experts to drive discussion alongside the audience Q&A.  Join us for this 30-minute webinar series that will help you stay up to date on the latest developments.